Polycythemia Vera Market Share, Size, Trends and

Document technical information

Format pdf
Size 255.3 kB
First found Apr 24, 2016

Document content analysis

Category Also themed
not defined
no text concepts found



Polycythemia Vera Market Share, Size, Trends and Growth,
Research Report and Forecasts, Pipeline Review, H1 2016
Global Markets Direct's, 'Polycythemia Vera - Pipeline Review, H1 2016', provides an overview of the
Polycythemia Vera pipeline landscape.
The report provides comprehensive information on the therapeutics under development for
Polycythemia Vera, complete with analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and development history and latest
news and press releases. Additionally, the report provides an overview of key players involved in
therapeutic development for Polycythemia Vera and features dormant and discontinued projects.
Browse Detail Report With TOC @ http://www.radiantinsights.com/research/polycythemia-verapipeline-review-h1-2016
The report provides a snapshot of the global therapeutic landscape of Polycythemia Vera
The report reviews pipeline therapeutics for Polycythemia Vera by companies and universities/research
institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
Table Of Content
Table of Contents 2
List of Tables 5
Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/167921
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Polycythemia Vera Overview 7
Therapeutics Development 8
Pipeline Products for Polycythemia Vera - Overview 8
Polycythemia Vera - Therapeutics under Development by Companies 9
Polycythemia Vera - Pipeline Products Glance 10
Late Stage Products 10
Clinical Stage Products 11
Early Stage Products 12
Polycythemia Vera - Products under Development by Companies 13
Polycythemia Vera - Companies Involved in Therapeutics Development 14
Bristol-Myers Squibb Company 14
Galena Biopharma, Inc. 15
Gilead Sciences, Inc. 16
Italfarmaco S.p.A. 17
Karus Therapeutics Limited 18
Merck & Co., Inc. 19
Browse Full Report @ http://www.radiantinsights.com/research/polycythemia-vera-pipeline-review-h12016
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over extensive database of
reports, our experienced research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]

Report this document